Depletion of macrophages in melanoma-bearing mice reduced the levels of IL-6 during PD-1/PD-L1 blockade, suggesting that IL-6-neutralizing antibodies are potential candidates for combination with anti-PD-1 antibodies (125). Here, IL6 is linked to melanoma.